These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 38532522)
1. Donepezil-induced bradycardia in a schizophrenic patient with comorbid neurocognitive disorder: a case report and review of the literature. Odenigbo N; Nkemjika S; Atolagbe A; Nwabueze C; Olwit C; Lawrence J; Olupona T J Med Case Rep; 2024 Mar; 18(1):129. PubMed ID: 38532522 [TBL] [Abstract][Full Text] [Related]
3. Beneficial effect of donepezil augmentation for the management of comorbid schizophrenia and dementia. Stryjer R; Strous RD; Bar F; Werber E; Shaked G; Buhiri Y; Kotler M; Weizman A; Rabey JM Clin Neuropharmacol; 2003; 26(1):12-7. PubMed ID: 12567159 [TBL] [Abstract][Full Text] [Related]
4. Bradycardia Due to Donepezil in Adults: Systematic Analysis of FDA Adverse Event Reporting System. Morris R; Luboff H; Jose RP; Eckhoff K; Bu K; Pham M; Rohlsen-Neal D; Cheng F J Alzheimers Dis; 2021; 81(1):297-307. PubMed ID: 33780370 [TBL] [Abstract][Full Text] [Related]
5. Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis. Battle CE; Abdul-Rahim AH; Shenkin SD; Hewitt J; Quinn TJ Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013306. PubMed ID: 33704781 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of low-dose donepezil in schizophrenia. Erickson SK; Schwarzkopf SB; Palumbo D; Badgley-Fleeman J; Smirnow AM; Light GA Clin Neuropharmacol; 2005; 28(4):179-84. PubMed ID: 16062097 [TBL] [Abstract][Full Text] [Related]
7. Cardiovascular effects and risk of syncope related to donepezil in patients with Alzheimer's disease. Bordier P; Garrigue S; Lanusse S; Margaine J; Robert F; Gencel L; Lafitte A CNS Drugs; 2006; 20(5):411-7. PubMed ID: 16696580 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial. Keefe RS; Malhotra AK; Meltzer HY; Kane JM; Buchanan RW; Murthy A; Sovel M; Li C; Goldman R Neuropsychopharmacology; 2008 May; 33(6):1217-28. PubMed ID: 17625502 [TBL] [Abstract][Full Text] [Related]
9. Use of clarithromycin and adverse cardiovascular events among older patients receiving donepezil: a population-based, nested case-control study. Hutson JR; Fischer HD; Wang X; Gruneir A; Daneman N; Gill SS; Rochon PA; Anderson GM Drugs Aging; 2012 Mar; 29(3):205-211. PubMed ID: 22372724 [TBL] [Abstract][Full Text] [Related]
10. Significance of syncope in patients with Alzheimer's disease treated with cholinesterase inhibitors. Bordier P; Garrigue S; Barold SS; Bressolles N; Lanusse S; Clémenty J Europace; 2003 Oct; 5(4):429-31. PubMed ID: 14753643 [TBL] [Abstract][Full Text] [Related]
11. The safety and tolerability of donepezil in patients with Alzheimer's disease. Jackson S; Ham RJ; Wilkinson D Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):1-8. PubMed ID: 15496217 [TBL] [Abstract][Full Text] [Related]
12. Donepezil: a clinical review of current and emerging indications. Román GC; Rogers SJ Expert Opin Pharmacother; 2004 Jan; 5(1):161-80. PubMed ID: 14680445 [TBL] [Abstract][Full Text] [Related]
13. Donepezil overdose: a tenfold dosing error. Shepherd G; Klein-Schwartz W; Edwards R Ann Pharmacother; 1999; 33(7-8):812-5. PubMed ID: 10466911 [TBL] [Abstract][Full Text] [Related]
14. Cholinesterase inhibitors as adjunctive therapy in patients with schizophrenia and schizoaffective disorder: a review and meta-analysis of the literature. Ribeiz SR; Bassitt DP; Arrais JA; Avila R; Steffens DC; Bottino CM CNS Drugs; 2010 Apr; 24(4):303-17. PubMed ID: 20297855 [TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting. Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990 [TBL] [Abstract][Full Text] [Related]
16. Donepezil-associated bradyarrhythmia in a patient with dementia with Lewy bodies (DLB). Rosenbloom MH; Finley R; Scheinman MM; Feldman MD; Miller BL; Rabinovici GD Alzheimer Dis Assoc Disord; 2010; 24(2):209-11. PubMed ID: 20505440 [TBL] [Abstract][Full Text] [Related]
17. Comparative risk of cardiac arrhythmias associated with acetylcholinesterase inhibitors used in treatment of dementias - A narrative review. Huang Y; Alsabbagh MW Pharmacol Res Perspect; 2020 Aug; 8(4):e00622. PubMed ID: 32691984 [TBL] [Abstract][Full Text] [Related]